The DOI matches its Crossref record; 70 of the 70 references it cites were found in a registry or an index; none of the 66 sources its claims cite is checked for support yet.
Matrix-Mediated Delivery of Silver Nanoparticles for Prevention of Staphylococcus aureus and Pseudomonas aeruginosa Biofilm Formation in Chronic Rhinosinusitis
Open accessAbstract
Chronic rhinosinusitis (CRS) is a chronic health condition affecting the sinonasal cavity. CRS-associated mucosal inflammation leads to sinonasal epithelial cell death and epithelial cell barrier disruption, which may result in recurrent bacterial infections and biofilm formation. For patients who fail medical management and elect endoscopic sinus surgery for disease control, bacterial biofilm formation is particularly detrimental, as it reduces the efficacy of surgical intervention. Effective treatments that prevent biofilm formation in post-operative patients in CRS are currently limited. To address this unmet need, we report the controlled release of silver nanoparticles (AgNps) with silk-elastinlike protein-based polymers (SELPs) to prevent bacterial biofilm formation in CRS. This polymeric network is liquid at room temperature and forms a hydrogel at body temperature, and is hence, capable of conforming to the sinonasal cavity upon administration. SELP hydrogels demonstrated sustained AgNp and silver ion release for the studied period of three days, potent in vitro antibacterial activity against Pseudomonas aeruginosa (**** p < 0.0001) and Staphylococcus aureus (**** p < 0.0001), two of the most commonly virulent bacterial strains observed in patients with post-operative CRS, and high cytocompatibility with human nasal epithelial cells. Antibacterial controlled release platform shows promise for treating patients suffering from prolonged sinonasal cavity infections due to biofilms.
Overview
CoChat Summary
TL;DR
A silk-elastinlike protein (SELP-815K) thermoresponsive hydrogel with hyaluronic acid and silver nanoparticles was developed as an antibacterial dressing for chronic rhinosinusitis. In vitro, the formulation released silver over 3 days, killed planktonic S. aureus and P. aeruginosa, prevented biofilm formation, and remained cytocompatible at the selected 625 µg/mL AgNp dose.
Key findings
- SELP/HA/AgNps (625 µg/mL) showed sustained, non-burst Ag+ release in simulated nasal fluid: cumulative release at 6 h was 8.31 ± 1.10% and at 72 h was 18.29 ± 2.86%; SELP/AgNps released 11.58 ± 1.82% at 6 h and 26.16 ± 4.68% at 72 h.
- The hydrogel produced complete bactericidal effect against planktonic S. aureus and P. aeruginosa, comparable to ciprofloxacin; SELP/HA without AgNps did not reduce CFU/mL. MIC for both strains was 7.8 µg/mL, and the highest MBC was 125 µg/mL, guiding selection of 625 µg/mL (5× MBC) for formulation development.
- In the colony biofilm assay, SELP/HA/AgNps (625 µg/mL) significantly prevented biofilm formation for S. aureus (p < 0.0001) and P. aeruginosa (p < 0.0001), with SEM showing absence of biofilm and bacterial growth.
- Cytocompatibility: free AgNps at 625 and 1250 µg/mL reduced HNEpC viability to 7.36 ± 0.37% and 8.21 ± 0.45%, respectively; SELP/HA/AgNps at 625 µg/mL gave 77.89 ± 5.12% viability (p = 0.008), while 1250 µg/mL gave 59.76 ± 10.05% (p = 0.0215). Rheology showed SELP/HA/AgNps viscosity increased from 1.02 ± 0.86 Pa s at 4 °C to 1.31 ± 0.41 Pa s at 23 °C to 5.01 ± 0.87 Pa s at 34 °C, with gelation <60 s at 34 °C.
Methods
- In vitro formulation characterization: PVP-coated AgNps were characterized by UV-Vis, TEM (6.2 ± 1.4 nm diameter), DLS, and ICP/MS. MIC/MBC were determined by macro dilution against S. aureus ATCC 25923 and P. aeruginosa ATCC 27853. HA concentration was optimized using LPS-stimulated THP-1 macrophages and IL-6/IL-8 ELISA, selecting 2 mg/mL.
- Efficacy and compatibility assays: HNEpC cytocompatibility was measured by CCK-8; antibacterial effect by viable count assay; biofilm prevention by colony biofilm assay on polycarbonate membranes with CFU counts and SEM. Ag+ release was measured in simulated nasal fluid over 72 h by ICP/MS.
- Rheology and statistics: viscosity was measured from 4 °C to 34 °C, and storage/loss moduli were measured at 34 °C by oscillatory sweep. Statistical comparisons used one-way ANOVA with Tukey’s multiple comparison tests; p < 0.05 was significant. Biological replicates were N = 2 and technical replicates n = 3 unless otherwise noted.
Limitations
- Stated: bactericidal effects were tested against single bacterial species, not multi-bacterial or patient-derived resistant strains; biofilm disruption was not studied; release kinetics could be further optimized by altering SELP and HA concentrations; other non-antibiotic antibacterial agents were not included; HA’s wound-healing/mucosal-regeneration effects require in vivo study; and free HA release and its interactions with the hydrogel network and silver nanoparticles need detailed analysis.
- Evident from the text: all reported antibacterial, antibiofilm, cytocompatibility, release, and rheological data are in vitro only, with no in vivo or clinical efficacy/safety data. The release study covers only 72 h, so longer-term release and biofilm prevention are not established.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures









Verification
Claims the paper makes
0 Valid · 0 Not valid · 32 Not checked · 60 Own results and interpretations
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Formulations containing 1250 µg/mL AgNps, significantly decreased HNEpCs’ viability (59.76 ± 10.05%; p = 0.0215)”
§ Matrix-Mediated Delivery of Silver Nanoparticles for Prevention of Staphylococcus aureus and Pseudomonas aeruginosa Biofilm Formation in Chronic Rhinosinusitis > 3. Results > 3.4. Cytocompatibility of Free AgNps and Hydrogel Formulations
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper states — it cites no source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Treatment with the SELP/HA/AgNps (625 µg/mL) significantly prevented biofilm formation of both strains, mainly due to the sustained release of AgNps/Ag+ ions, which enhances the efficacy and reduces the toxicity associated with AgNps and Ag+ ions.”
§ Matrix-Mediated Delivery of Silver Nanoparticles for Prevention of Staphylococcus aureus and Pseudomonas aeruginosa Biofilm Formation in Chronic Rhinosinusitis > 4. Discussion
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The free form of AgNps showed cytocompatibility only at 125 µg/mL concentration (cell viability 83.28 ± 5.63%) (Figure 3B).”
§ Matrix-Mediated Delivery of Silver Nanoparticles for Prevention of Staphylococcus aureus and Pseudomonas aeruginosa Biofilm Formation in Chronic Rhinosinusitis > 3. Results > 3.4. Cytocompatibility of Free AgNps and Hydrogel Formulations
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Thus, the highest MBC concentration obtained (125 µg/mL) was selected for formulation development.”
§ Matrix-Mediated Delivery of Silver Nanoparticles for Prevention of Staphylococcus aureus and Pseudomonas aeruginosa Biofilm Formation in Chronic Rhinosinusitis > 3. Results > 3.2. Identification of MIC and MBC of AgNps against S. aureus and P. aeruginosa
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The viable count assay showed that the finalized formulation containing SELP/HA/AgNps (625 µg/mL) eliminated bacterial growth of both strains (S. aureus and P. aeruginosa; Figure 4).”
§ Matrix-Mediated Delivery of Silver Nanoparticles for Prevention of Staphylococcus aureus and Pseudomonas aeruginosa Biofilm Formation in Chronic Rhinosinusitis > 4. Discussion
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
56 more claims
Create a free account to see all 92 claims and to verify the 66 references still open.
- It may state two separate claims as one. 21
- Probably not a substantial claim. 10
- The quote only partly states this claim. 1
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Matrix-Mediated Delivery of Silver Nanoparticles for Prevention of Staphylococcus aureus and Pseudomonas aeruginosa Biofilm Formation in Chronic Rhinosinusitis > 3. Results > 3.7. Assessment of AgNps Release from Hydrogels
“The SEM analysis of SELP/HA/AgNps (625 µg/mL) hydrogel after 24 h of incubation in SNF showed nanoparticle interaction with the SELPs backbone (Figure 8B), leading to sustained release of Ag+ ions.”
§ Matrix-Mediated Delivery of Silver Nanoparticles for Prevention of Staphylococcus aureus and Pseudomonas aeruginosa Biofilm Formation in Chronic Rhinosinusitis > 4. Discussion
“We hypothesize that the sustained Ag+ ion released from our formulation was due to AgNp-SELP-815K interactions, as demonstrated using SEM (Figure 8C).”
Citations
Cites
Wiegand, I., Hilpert, K., & Hancock, R. E. W. (2008) · Nature Protocols · doi:10.1038/nprot.2007.521 · Cited by 6,156
European Position Paper on Rhinosinusitis and Nasal Polyps 2020
Fokkens, W. J., Lund, V. J., Hopkins, C., Hellings, P. W., Kern, R., Reitsma, S., Toppila-Salmi, S., Bernal-Sprekelsen, M., Mullol, J., Alobid, I., et al. (2020) · Rhinology journal · doi:10.4193/rhin20.600 · Cited by 5,882
The antimicrobial activity of nanoparticles: present situation and prospects for the future
Wang, L., Hu, C., & Shao, L. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s121956 · Cited by 4,062
Metal nanoparticles: understanding the mechanisms behind antibacterial activity
Slavin, Y. N., Asnis, J., Häfeli, U. O., & Bach, H. (2017) · Journal of Nanobiotechnology · doi:10.1186/s12951-017-0308-z · Cited by 2,571
Bachert, C., Han, J. K., Desrosiers, M., Hellings, P. W., Amin, N., Lee, S. E., Mullol, J., Greos, L. S., Bosso, J. V., Laidlaw, T. M., et al. (2019) · The Lancet · doi:10.1016/s0140-6736(19)31881-1 · Cited by 1,563
EPOS2020: A Major Step Forward
Fokkens, W. J. (2020) · Rhinology journal · doi:10.4193/rhin20.401 · Cited by 1,240
Bacterial Biofilm and its Role in the Pathogenesis of Disease
Vestby, L. K., Grønseth, T., Simm, R., & Nesse, L. L. (2020) · Antibiotics · doi:10.3390/antibiotics9020059 · Cited by 1,105
Growing and Analyzing Static Biofilms
Merritt, J. H., Kadouri, D. E., & O'Toole, G. A. (2006) · Current Protocols in Microbiology · doi:10.1002/9780471729259.mc01b01s00 · Cited by 1,086
Bactericidal and Cytotoxic Properties of Silver Nanoparticles
Liao, C., Li, Y., & Tjong, S. C. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20020449 · Cited by 1,059
International consensus statement on allergy and rhinology: rhinosinusitis 2021
Orlandi, R. R., Kingdom, T. T., Smith, T. L., Bleier, B., DeConde, A., Luong, A. U., Poetker, D. M., Soler, Z., Welch, K. C., Wise, S. K., et al. (2021) · International Forum of Allergy & Rhinology · doi:10.1002/alr.22741 · Cited by 959
Self-citationIn situ forming injectable hydrogels for drug delivery and wound repair
Dimatteo, R., Darling, N. J., & Segura, T. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.03.007 · Cited by 896
Chronic Rhinosinusitis with Nasal Polyps and Asthma
Laidlaw, T. M., Mullol, J., Woessner, K. M., Amin, N., & Mannent, L. P. (2021) · The Journal of Allergy and Clinical Immunology: In Practice · doi:10.1016/j.jaip.2020.09.063 · Cited by 419
Sim, W., Barnard, R. T., Blaskovich, M. A. T., & Ziora, Z. M. (2018) · Antibiotics · doi:10.3390/antibiotics7040093 · Cited by 370
Genetic Engineering of Structural Protein Polymers
Cappello, J., Crissman, J., Dorman, M., Mikolajczak, M., Textor, G., Marquet, M., & Ferrari, F. (1990) · Biotechnology Progress · doi:10.1021/bp00003a006 · Cited by 323
Bendouah, Z., Barbeau, J., Hamad, W. A., & Desrosiers, M. (2006) · Otolaryngology–Head and Neck Surgery · doi:10.1016/j.otohns.2006.03.001 · Cited by 279
Microscopy Methods for Biofilm Imaging: Focus on SEM and VP-SEM Pros and Cons
Relucenti, M., Familiari, G., Donfrancesco, O., Taurino, M., Li, X., Chen, R., Artini, M., Papa, R., & Selan, L. (2021) · Biology · doi:10.3390/biology10010051 · Cited by 228
Cytotoxicity of Nanoparticles Contained in Food on Intestinal Cells and the Gut Microbiota
Fröhlich, E., & Fröhlich, E. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17040509 · Cited by 223
Calus, L., Van Bruaene, N., Bosteels, C., Dejonckheere, S., Van Zele, T., Holtappels, G., Bachert, C., & Gevaert, P. (2019) · Clinical and Translational Allergy · doi:10.1186/s13601-019-0269-4 · Cited by 210
Characterization of Bacterial and Fungal Biofilms in Chronic Rhinosinusitis
Foreman, A., Psaltis, A. J., Tan, L. W., & Wormald, P.-J. (2009) · American Journal of Rhinology & Allergy · doi:10.2500/ajra.2009.23.3413 · Cited by 195
Mycofabricated biosilver nanoparticles interrupt Pseudomonas aeruginosa quorum sensing systems
Singh, B. R., Singh, B. N., Singh, A., Khan, W., Naqvi, A. H., & Singh, H. B. (2015) · Scientific Reports · doi:10.1038/srep13719 · Cited by 192
Bacterial Quorum-Sensing Systems and Their Role in Intestinal Bacteria-Host Crosstalk
Wu, L., & Luo, Y. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.611413 · Cited by 159
de Lacerda Coriolano, D., de Souza, J. B., Bueno, E. V., Medeiros, S. M. D. F. R., Cavalcanti, I. D. L., & Cavalcanti, I. M. F. (2021) · Brazilian Journal of Microbiology · doi:10.1007/s42770-020-00406-x · Cited by 158
Burns and biofilms: priority pathogens and in vivo models
Maslova, E., Eisaiankhongi, L., Sjöberg, F., & McCarthy, R. R. (2021) · npj Biofilms and Microbiomes · doi:10.1038/s41522-021-00243-2 · Cited by 149
Sleep quality and disease severity in patients with chronic rhinosinusitis
Alt, J. A., Smith, T. L., Mace, J. C., & Soler, Z. M. (2013) · The Laryngoscope · doi:10.1002/lary.24040 · Cited by 147
Self-citationHaidari, H., Kopecki, Z., Bright, R., Cowin, A. J., Garg, S., Goswami, N., & Vasilev, K. A. (2020) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.0c09414 · Cited by 142
The impact of biofilms on outcomes after endoscopic sinus surgery
Singhal, D., Psaltis, A. J., Foreman, A., & Wormald, P.-J. (2010) · American Journal of Rhinology & Allergy · doi:10.2500/ajra.2010.24.3462 · Cited by 139
Lourijsen, E. S., Reitsma, S., Vleming, M., Hannink, G., Adriaensen, G. F. J. P. M., Cornet, M., Hoven, R. D., Videler, W. J. M., Bretschneider, J. H., Reinartz, S. M., et al. (2022) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(21)00457-4 · Cited by 122
Brandsted, R., & Sindwani, R. H. (2007) · American Journal of Rhinology · doi:10.2500/ajr.2007.21.2987 · Cited by 108
The pathophysiological role of bacterial biofilms in chronic sinusitis
Długaszewska, J., Leszczyńska, M., Lenkowski, M., Tatarska, A., Pastusiak, T., & Szyfter, W. (2015) · European Archives of Oto-Rhino-Laryngology · doi:10.1007/s00405-015-3650-5 · Cited by 94
A cross-sectional, population-based survey of U.S. adults with symptoms of chronic rhinosinusitis
Palmer, J. N., Messina, J. C., Biletch, R., Grosel, K., & Mahmoud, R. A. (2018) · Allergy and Asthma Proceedings · doi:10.2500/aap.2019.40.4182 · Cited by 93
Biofilms in chronic rhinosinusitis: Pathophysiology and therapeutic strategies
Fastenberg, J. H., Hsueh, W. D., Mustafa, A., Akbar, N. A., & Abuzeid, W. M. (2016) · World Journal of Otorhinolaryngology - Head and Neck Surgery · doi:10.1016/j.wjorl.2016.03.002 · Cited by 92
Role of bacterial and fungal biofilms in chronic rhinosinusitis
Foreman, A., Boase, S., Psaltis, A., & Wormald, P.-J. (2012) · Current Allergy and Asthma Reports · doi:10.1007/s11882-012-0246-7 · Cited by 89
Dandu, R., Cresce, A. V., Briber, R., Dowell, P., Cappello, J., & Ghandehari, H. (2009) · Polymer · doi:10.1016/j.polymer.2008.11.047 · Cited by 70
Self-citationIn situ gelling silk-elastinlike protein polymer for transarterial chemoembolization
Poursaid, A., Price, R., Tiede, A., Olson, E., Huo, E., McGill, L., Ghandehari, H., & Cappello, J. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2015.04.015 · Cited by 62
Self-citationA gelatin-thrombin matrix for hemostasis after endoscopic sinus surgery
Woodworth, B. A., Chandra, R. K., LeBenger, J. D., Ilie, B., & Schlosser, R. J. (2009) · American Journal of Otolaryngology · doi:10.1016/j.amjoto.2007.11.008 · Cited by 56
Loo, C., Young, P. M., Lee, W., Cavaliere, R., Whitchurch, C. B., & Rohanizadeh, R. (2014) · Biofouling · doi:10.1080/08927014.2014.926475 · Cited by 54
Endoscopic sinus surgery improves cognitive dysfunction in patients with chronic rhinosinusitis
Alt, J. A., Mace, J. C., Smith, T. L., & Soler, Z. M. (2016) · International Forum of Allergy & Rhinology · doi:10.1002/alr.21820 · Cited by 52
Self-citationTian, D.-M., Wan, H.-H., Chen, J.-R., Ye, Y.-B., He, Y., Liu, Y., Tang, L.-Y., He, Z.-Y., Liu, K.-Z., Gao, C.-J., et al. (2022) · Materials Today Bio · doi:10.1016/j.mtbio.2022.100300 · Cited by 49
Liu, T., Aman, A., Ainiwaer, M., Ding, L., Zhang, F., Hu, Q., Song, Y., Ni, Y., & Tang, X. (2021) · Scientific Reports · doi:10.1038/s41598-021-92081-7 · Cited by 45
Silk-elastinlike protein-based hydrogels for drug delivery and embolization
Griswold, E., Cappello, J., & Ghandehari, H. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114579 · Cited by 45
Self-citationSmith, A., Buchinsky, F. J., & Post, J. C. (2011) · Otolaryngology–Head and Neck Surgery · doi:10.1177/0194599810391620 · Cited by 44
Poursaid, A., Jensen, M. M., Nourbakhsh, I., Weisenberger, M., Hellgeth, J. W., Sampath, S., Cappello, J., & Ghandehari, H. (2016) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.6b00325 · Cited by 42
Self-citationJensen, M. M., Jia, W., Schults, A. J., Isaacson, K. J., Steinhauff, D., Green, B., Zachary, B., Cappello, J., Ghandehari, H., & Oottamasathien, S. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2019.119293 · Cited by 41
Self-citationMacrolide therapy for chronic rhinosinusitis: A meta-analysis
Pynnonen, M. A., Venkatraman, G., & Davis, G. E. (2013) · Otolaryngology–Head and Neck Surgery · doi:10.1177/0194599812470427 · Cited by 40
Understanding the Role of Biofilms and Superantigens in Chronic Rhinosinusitis
Maina, I. W., Patel, N. N., & Cohen, N. A. (2018) · Current Otorhinolaryngology Reports · doi:10.1007/s40136-018-0212-6 · Cited by 40
Schilling, A. L., Kulahci, Y., Moore, J., Wang, E. W., Lee, S. E., & Little, S. R. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.10.062 · Cited by 40
Lux, C. A., Wagner Mackenzie, B., Johnston, J., Zoing, M., Biswas, K., Taylor, M. W., & Douglas, R. G. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.595555 · Cited by 36
Inhibition of Bacterial Growth by Peptide-Conjugated Morpholino Oligomers
Daly, S. M., Sturge, C. R., & Greenberg, D. E. (2017) · Methods in molecular biology · doi:10.1007/978-1-4939-6817-6_10 · Cited by 35
Hyaluronan in the Treatment of Chronic Rhinosinusitis with Nasal Polyposis
Cassandro, E., Chiarella, G., Cavaliere, M., Sequino, G., Cassandro, C., Prasad, S. C., Scarpa, A., & Iemma, M. (2015) · Indian Journal of Otolaryngology and Head & Neck Surgery · doi:10.1007/s12070-014-0766-7 · Cited by 33
Yao, Y., Wang, Z., Liu, J., Ma, J., Chen, C., Deng, Y., Liao, B., Wang, N., Wang, H., Ning, Q., et al. (2017) · International Forum of Allergy & Rhinology · doi:10.1002/alr.21984 · Cited by 33
Jensen, M. M., Jia, W., Isaacson, K. J., Schults, A., Cappello, J., Prestwich, G. D., Oottamasathien, S., & Ghandehari, H. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.02.025 · Cited by 30
Self-citationAdvances in controlled drug delivery to the sinonasal mucosa
Schilling, A. L., Cannon, E., Lee, S. E., Wang, E. W., & Little, S. R. (2022) · Biomaterials · doi:10.1016/j.biomaterials.2022.121430 · Cited by 30
Hyaluronic acid for post sinus surgery care: Systematic review and meta-analysis
Fong, E., Garcia, M., Woods, C. M., & Ooi, E. (2017) · The Journal of Laryngology & Otology · doi:10.1017/s0022215116009269 · Cited by 29
Price, R., Poursaid, A. E., Cappello, J., & Ghandehari, H. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.07.044 · Cited by 28
Self-citationIs there a role for antibiotics in the treatment of chronic rhinosinusitis?
Smith, S. S., Kim, R., & Douglas, R. (2022) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2022.02.004 · Cited by 28
Biofilm-forming bacteria and quality of life improvement after sinus surgery
Zhang, Z., Adappa, N. D., Chiu, A. G., Doghramji, L. J., Cohen, N. A., & Palmer, J. N. (2015) · International Forum of Allergy & Rhinology · doi:10.1002/alr.21505 · Cited by 27
The effect of endoscopic sinus surgery on bacterial biofilms in chronic rhinosinusitis
Hai, P. V. T., Lidstone, C., & Wallwork, B. (2010) · Otolaryngology–Head and Neck Surgery · doi:10.1016/j.otohns.2009.09.022 · Cited by 25
Topical Colloidal Silver for the Treatment of Recalcitrant Chronic Rhinosinusitis
Ooi, M. L., Richter, K., Bennett, C., Macias-Valle, L., Vreugde, S., Psaltis, A. J., & Wormald, P.-J. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.00720 · Cited by 25
Evolution in the surgical management of chronic rhinosinusitis: Current indications and pitfalls
Kohanski, M. A., Toskala, E. M., & Kennedy, D. W. (2018) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2018.03.003 · Cited by 23
Rajiv, S., Drilling, A., Bassiouni, A., James, C., Vreugde, S., & Wormald, P. (2015) · International Forum of Allergy & Rhinology · doi:10.1002/alr.21459 · Cited by 22
Jia, M., Chen, Z., Guo, Y., Chen, X., & Zhao, X. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s130160 · Cited by 22
Scott, J. R., Krishnan, R., Rotenberg, B. W., & Sowerby, L. J. (2017) · Journal of Otolaryngology - Head & Neck Surgery · doi:10.1186/s40463-017-0241-z · Cited by 21
Gurina, D. L., Surov, O. V., Voronova, M. I., Zakharov, A. G., & Киселев, М. Г. (2019) · Materials · doi:10.3390/ma12132155 · Cited by 21
Steinhauff, D., Jensen, M., Talbot, M., Jia, W., Isaacson, K., Jedrzkiewicz, J., Cappello, J., Oottamasathien, S., & Ghandehari, H. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.03.001 · Cited by 16
Self-citationSiu, J., Klingler, L., Wang, Y., Hung, C.-T., Jeong, S. H., Smith, S., Tingle, M. D., Wagner Mackenzie, B., Biswas, K., & Douglas, R. G. (2020) · Xenobiotica · doi:10.1080/00498254.2020.1814973 · Cited by 13
Hale, S. J. M., Wagner Mackenzie, B., Lux, C. A., Biswas, K., Kim, R., & Douglas, R. G. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.840323 · Cited by 13
Protein-based polymer liquid embolics for cerebral aneurysms
Jensen, M. M., Hatlevik, Ø., Steinhauff, D. B., Griswold, E. D., Wei, X., Isaacson, K. J., Barber, Z. B., Huo, E. J., Taussky, P., Jedrzkiewicz, J., et al. (2022) · Acta Biomaterialia · doi:10.1016/j.actbio.2022.08.003 · Cited by 7
Self-citationKaper, N. M., Aarts, M. C. J., Stokroos, R. J., & van der Heijden, G. J. M. G. (2019) · Clinical Otolaryngology · doi:10.1111/coa.13453 · Cited by 4
(2010) · PubMed
Pathophysiology of chronic rhinosinusitis, pharmaceutical therapy options
Bachert, C., & Holtappels, G. (2015) · German Medical Science GMS Publishing House · doi:10.3205/cto000124
Cited by
Elbehiry, A., & Abalkhail, A. (2025) · Pharmaceuticals · doi:10.3390/ph18081195 · Cited by 60
Kamath, S., Ariaee, A., Abdelhafez, A., Asif, Z., Chan, N. S. L., Collins, K., Hunter, A., & Joyce, P. M. (2025) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2025.115720 · Cited by 42
Nanotechnology-Based Therapeutics for Airway Inflammatory Diseases
Cui, L., Yang, Y., Hao, Y., Zhao, H., Zhang, Y., Wu, T., & Song, X. (2025) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-024-09019-w · Cited by 23
Tabrizi, E., & Li, B. (2025) · Materials Today Bio · doi:10.1016/j.mtbio.2025.102609 · Cited by 19
Evaluation of different antimicrobial polymeric coatings for food contact surfaces
Edo, G. I., Mafe, A. N., Ali, A. B. M., Akpoghelie, P. O., Yousif, E., Isoje, E. F., Igbuku, U. A., Zainulabdeen, K., Owheruo, J. O., Essaghah, A. E. A., et al. (2025) · Discover Food · doi:10.1007/s44187-025-00487-3 · Cited by 19
Metadata
- Authors
- Yathavan, B., Chhibber, T., Steinhauff, D., Pulsipher, A., Alt, J. A., Ghandehari, H., & Jafari, P.
- Affiliations
- University of Utah (US)
- Corresponding author
- Jafari, Paris
- Venue
- Pharmaceutics
- Publisher
- MDPI AG
- Published
- 2023-10-05
- Volume
- 15
- Issue
- 10
- Pages
- 2426
- ISSN
- 1999-4923 (ISSN-L)
- PMC
- PMC10610389
- OpenAlex
- W4387365943
- Semantic Scholar
- d6ae090f335c5f533b7f652bea9f84aa0b1b08b9
- Cited by
- 20
- References
- 70
- Citations by year
- 2026: 8 · 2025: 11 · 2024: 1
- FWCI
- 2.02
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Pharmaceutics (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- SERVAL (Université de Lausanne) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- IRIS (submittedVersion, cc-by)
- Funders
- Utah Clinical & Translational Science Institute (NCATS UL 1TR002538, UM1TR004409, 1K12TR004413)
- Skaggs Graduate Research Fellowship awarded by the University of Utah, College of Pharmacy (NCATS UL 1TR002538, UM1TR004409, 1K12TR004413)
- Research Incentive Seed Grant awarded by the University of Utah School of Medicine (NCATS UL 1TR002538, UM1TR004409, 1K12TR004413)
- National Center for Advancing Translational Sciences of the National Institutes of Health (NCATS UL 1TR002538, UM1TR004409, 1K12TR004413)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
- Health Sciences › Medicine › Otorhinolaryngology › Sinusitis and nasal conditions
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bacterial biofilms and quorum sensing
- Keywords
- chronic rhinosinusitis, bacterial biofilm prevention, silver nanoparticles, controlled release, silver ion release, Staphylococcus aureus, Pseudomonas aeruginosa, antibacterial activity, nasal epithelial cells, cytocompatibility, sinonasal infection, endoscopic sinus surgery
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-11-15, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-11-15 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.